Onderzoek naar geheugen en lichamelijke activiteit na behandeling van kanker bij overlevenden van adolescente en jonge volwassen kankers (IMPACT)
This study evaluates relationships among physical activity, thinking, and memory after cancer treatment in survivors of adolescent and young adult cancers.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Clinical Trials Referral Office
- Telefoonnummer: 855-776-0015
- E-mail: mayocliniccancerstudies@mayo.edu
Studie Contact Back-up
- Naam: Melissa Cole
- Telefoonnummer: 480-574-4052
- E-mail: mailto:ARZENL@mayo.edu
Studie Locaties
-
-
Arizona
-
Scottsdale, Arizona, Verenigde Staten, 85259
- Werving
- Mayo Clinic in Arizona
-
Contact:
- Clinical Trials Referral Office
- Telefoonnummer: 855-776-0015
- E-mail: mayocliniccancerstudies@mayo.edu
-
Contact:
- Melissa Cole
- Telefoonnummer: 480-574-4052
- E-mail: mailto:ARZENL@mayo.edu
-
Hoofdonderzoeker:
- Diane K. Ehlers, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Patients with primary diagnosis of cancer when 15-39 years old.
Beschrijving
Inclusion Criteria:
- Adults (aged 18+ years)
- Primary diagnosis of cancer when 15-39 years-old
- Access to a desktop computer or laptop with reliable internet access
- No gross motor impairments that prohibit ambulation
- Willing to complete study requirements
- English speaking
Exclusion Criteria:
- Diagnosed with nonmelanoma skin cancer only
- Not diagnosed with cancer in adolescent and young adult (AYA) age range of 15-39 years
- Scheduled travel during the study period that is not indicative of individual's normal schedule
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: CASE_ONLY
- Tijdsperspectieven: CROSS_SECTIONAL
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Observational
Patients complete questionnaires and cognitive tasks and wear an activity monitor to measure physical activity on study. Some patients may optionally participate in an interview on study. |
Non-Interventional Study |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cognitive performance on Stroop task
Tijdsspanne: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
Up to 4 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cognitive performance on Visual Memory Test
Tijdsspanne: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Verbal Memory Test
Tijdsspanne: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Symbol Digit Coding Test
Tijdsspanne: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Shifting Attention Test
Tijdsspanne: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Continuous Performance Test
Tijdsspanne: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). |
Up to 4 weeks
|
|
Cognitive performance on Reasoning Test
Tijdsspanne: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Four Part Continuous Performance Test
Tijdsspanne: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Self-reported cognition - FACT-COG
Tijdsspanne: 2 weeks
|
Evaluated using the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-COG), a 37-item questionnaire assessing cognitive impairment, cognitive abilities, and quality of life over the past 7 days. Responses are on a 5-point scale (Never; About once a week; Two to three times a week; Nearly every day; Several times a day). Higher scores generally indicate better self-reported cognition. |
2 weeks
|
|
Average weekly minutes of physical activity
Tijdsspanne: 2 weeks
|
Moderate-to-vigorous physical activity (MVPA) will be measured using an accelerometer (activPAL) which participants will wear on their non-dominant thigh for 7 consecutive days. |
2 weeks
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Diane K. Ehlers, PhD, Mayo Clinic
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 24-008654
- 24-008654 (Andere identificatie: Mayo Clinic Institutional Review Board)
- NCI-2025-01193 (Register-ID: CTRP (Clinical Trial Reporting Program))
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
De-identified, limited datasets will be shared with other researchers upon request or according to journal publication requirements
IPD-tijdsbestek voor delen
At time of first publication (as required by journals) until last manuscript is published.
IPD-toegangscriteria voor delen
If required by journal and case by case upon request to the PI
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .